SK

Sekar Kothandaraman

Active Director Director DIN 07347496
DIN 07347496 First appointment Dec 2015 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Dec 2015
Shareholding value •••• Premium profile

About Sekar Kothandaraman

Data last updated:

Sekar Kothandaraman has 10 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Roarmed Pharmaceuticals Private Limited and Serobidh Healthcare Private Limited. Formerly with 3 companies, such as Dr. Miltons Laboratories Private Limited and Unity Flexi Pack Global Private Limited. Engaged in General Business, Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.54 Cr; the largest is Serobidh Healthcare Private Limited at ₹2.21 Cr (FY 2024).

DIN 07347496
Primary Designation Director
First Appointment 07 Dec 2015
Oldest Company Age 11 yrs
Largest company Serobidh Healthcare Private Limited · ₹2.21 Cr (FY 2024)
Combined revenue ₹3.54 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Serobidh Healthcare Private Limited U24290TN2022PTC149592
Additional Director15 Nov 20242022₹2.21 Cr (FY 2024)Active
Mimulus Laboratories Private Limited U24295PY2015PTC002977
Director10 Feb 20232015₹1.33 Cr (FY 2025)Active
Director07 Jun 20252024–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20192007₹35.09 Cr (FY 2025)Active
Director07 Dec 20152015₹5.84 Cr (FY 2025)Active
Yamuna Roto Prints Private Limited U21012TN2016PTC104284
Director25 Jun 20162016–Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Roarmed Pharmaceuticals Private Limited
Serobidh Healthcare Private Limited
Mimulus Laboratories Private Limited
Dr. Miltons Laboratories Private Limited
Premium access

Shareholding and investment profile for Sekar Kothandaraman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekar Kothandaraman

Sekar Kothandaraman has 10 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Roarmed Pharmaceuticals Private Limited and Serobidh Healthcare Private Limited. Formerly with 3 companies, such as Dr. Miltons Laboratories Private Limited and Unity Flexi Pack Global Private Limited. Engaged in General Business, Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.54 Cr; the largest is Serobidh Healthcare Private Limited at ₹2.21 Cr (FY 2024).

Sekar Kothandaraman is associated with 3 companies as Director and Additional Director, including Serobidh Healthcare Private Limited (₹2.21 Cr), Mimulus Laboratories Private Limited (₹1.33 Cr), Roarmed Pharmaceuticals Private Limited.

Sekar Kothandaraman has expertise in General Business, Healthcare.

Sekar Kothandaraman has 10 years in corporate governance.

By reported revenue, the largest current company of Sekar Kothandaraman is Serobidh Healthcare Private Limited, with revenue of ₹2.21 Cr (FY 2024).

The 2 current companies of Sekar Kothandaraman that report revenue have a combined latest revenue of ₹3.54 Cr.

Sekar Kothandaraman currently holds positions at 3 companies: Serobidh Healthcare Private Limited (₹2.21 Cr), Mimulus Laboratories Private Limited (₹1.33 Cr), Roarmed Pharmaceuticals Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available